Replies to The clinical targeted drug I received and still take is Rubraca (Rucaparib). It is a biosimilar…

Discussion

Pancreatic Cancer | Last Active: Aug 29, 2023 | Replies (76)

Comment receiving replies

@stageivsurvivor

The clinical targeted drug I received and still take is Rubraca (Rucaparib). It is a biosimilar drug to Lynparza (Olaparib).

Replies to "The clinical targeted drug I received and still take is Rubraca (Rucaparib). It is a biosimilar..."

mamarina | @mamarina | Mar 3, 2023

Stage Iv
Did you need a certain mutation to qualify?